Scientists hunt for clues in rare muscle disease
NCT ID NCT06096441
Summary
This study aimed to better understand Facioscapulohumeral Muscular Dystrophy (FSHD) by measuring specific biological markers in muscle tissue and testing if MRI scans could help find the best spots to sample. It involved people aged 13+ with genetically confirmed FSHD. The study was terminated early after enrolling only one participant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FACIO-SCAPULO-HUMERAL DYSTROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Abigail Wexner Research Institute at Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
Conditions
Explore the condition pages connected to this study.